Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ESLA Estrella Immunopharma

休市中 01-09 16:00:00 EST

1.20

-0.22

-15.49%

盘后1.20

+0.00-0.24%

19:52 EST

最高1.51	最低1.07	成交量18.47万
今开1.48	昨收1.42	日振幅31.04%
总市值5,044万	流通市值2,087万	总股本4,203万
成交额22.32万	换手率1.06%	流通股本1,739万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ESLA","market":"US","secType":"STK","nameCN":"Estrella Immunopharma","latestPrice":1.2,"timestamp":1767992400000,"preClose":1.42,"halted":0,"volume":184687,"hourTrading":{"tag":"盘后","latestPrice":1.1971,"preClose":1.2,"latestTime":"19:52 EST","volume":2091,"amount":2504.7903,"timestamp":1768006377251},"delay":0,"floatShares":17391600,"shares":42034200,"eps":-0.367652,"marketStatus":"休市中","change":-0.22,"latestTime":"01-09 16:00:00 EST","open":1.48,"high":1.5107,"low":1.07,"amount":223243.975709,"amplitude":0.310352,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.367652,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1768208400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.42,"preHourTrading":{"tag":"盘前","latestPrice":1.5497,"preClose":1.42,"latestTime":"09:26 EST","volume":4,"amount":6.1794,"timestamp":1767968815219},"postHourTrading":{"tag":"盘后","latestPrice":1.1971,"preClose":1.2,"latestTime":"19:52 EST","volume":2091,"amount":2504.7903,"timestamp":1768006377251},"volumeRatio":2.096490768357739},"requestUrl":"/m/hq/s/ESLA","defaultTab":"news","newsList":[{"id":"1102194995","title":"Estrella Immunopharma完成800万美元注册直接发行与同步私募配售","url":"https://stock-news.laohu8.com/highlight/detail?id=1102194995","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102194995?lang=zh_cn&edition=full","pubTime":"2026-01-07 03:02","pubTimestamp":1767726148,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma（股票代码：ESLA）宣布成功完成800万美元的注册直接发行及同步进行的私募配售。此次融资将用于推进公司核心免疫疗法管线的临床开发，增强企业资本结构。通过结合公开市场发行与私募融资的双轨策略，公司展现了在复杂市场环境中灵活获取资本的执行能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLA","ESLAW","BK4139"],"gpt_icon":0},{"id":"2601869472","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨5.06%报1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601869472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601869472?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:33","pubTimestamp":1767623580,"startTime":"0","endTime":"0","summary":"北京时间2026年01月05日22时33分，Estrella Immunopharma, Inc.股票出现异动，股价急速上涨5.06%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105223301953c03ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105223301953c03ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"1141368458","title":"Estrella Immunopharma公司宣布800万美元注册直接发行及同步私募配售，按纳斯达克规则以市价定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1141368458","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141368458?lang=zh_cn&edition=full","pubTime":"2026-01-05 21:30","pubTimestamp":1767619823,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma公司已正式披露一项融资计划，将实施总额800万美元的注册直接发行，并同步开展私募配售。此次发行的定价将严格遵循纳斯达克市场规则，采用市价定价机制。该举措旨在为公司的免疫药物研发及业务拓展注入新的资金动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2594094264","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨6.58%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594094264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594094264?lang=zh_cn&edition=full","pubTime":"2025-12-25 01:23","pubTimestamp":1766596990,"startTime":"0","endTime":"0","summary":"北京时间2025年12月25日01时23分，Estrella Immunopharma, Inc.股票出现异动，股价急速拉升6.58%。截至发稿，该股报1.62美元/股，成交量6300股，换手率0.02%，振幅4.61%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122501231097a0a771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122501231097a0a771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"1113157198","title":"Estrella Immunopharma - 提供高达2,541,206股的转售机会给售股股东 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1113157198","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113157198?lang=zh_cn&edition=full","pubTime":"2025-12-22 23:58","pubTimestamp":1766419092,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma - 提供高达2,541,206股的转售机会给售股股东 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2588032226","title":"Estrella Immunopharma, Inc.盘中异动 早盘大幅跳水5.21%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588032226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588032226?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:51","pubTimestamp":1764600673,"startTime":"0","endTime":"0","summary":"北京时间2025年12月01日22时51分，Estrella Immunopharma, Inc.股票出现波动，股价急速下跌5.21%。截至发稿，该股报2.00美元/股，成交量2.5864万股，换手率0.07%，振幅9.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201225113a71d2844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201225113a71d2844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2586129096","title":"Estrella Immunopharma, Inc.盘中异动 早盘快速上涨6.93%报1.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586129096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586129096?lang=zh_cn&edition=full","pubTime":"2025-11-26 22:34","pubTimestamp":1764167682,"startTime":"0","endTime":"0","summary":"北京时间2025年11月26日22时34分，Estrella Immunopharma, Inc.股票出现波动，股价急速上涨6.93%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Scisparc Ltd.、Quantum Biopharma Ltd.涨幅较大，Scisparc Ltd.、Kala Bio, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为1809.05%、154.82%、41.09%，振幅较大的相关个股有Quantum Biopharma Ltd.、Pasithea Therapeutics Corp.、Scisparc Ltd.，振幅分别为20.40%、10.89%、9.45%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126223442951bd857&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126223442951bd857&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2586781304","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大涨5.26%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586781304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586781304?lang=zh_cn&edition=full","pubTime":"2025-11-24 23:52","pubTimestamp":1763999523,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日23时52分，Estrella Immunopharma, Inc.股票出现异动，股价快速上涨5.26%。截至发稿，该股报1.60美元/股，成交量2.171万股，换手率0.06%，振幅4.61%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124235203a70ea86a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124235203a70ea86a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2585711371","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨5.43%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585711371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585711371?lang=zh_cn&edition=full","pubTime":"2025-11-20 22:36","pubTimestamp":1763649413,"startTime":"0","endTime":"0","summary":"北京时间2025年11月20日22时36分，Estrella Immunopharma, Inc.股票出现波动，股价急速拉升5.43%。截至发稿，该股报1.85美元/股，成交量9935股，换手率0.03%，振幅3.43%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.23%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120223653a4af7c96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120223653a4af7c96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2584963539","title":"Estrella Immunopharma, Inc.盘中异动 快速跳水6.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584963539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584963539?lang=zh_cn&edition=full","pubTime":"2025-11-19 01:30","pubTimestamp":1763487003,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日01时30分，Estrella Immunopharma, Inc.股票出现波动，股价快速下跌6.18%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111901300397719f9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111901300397719f9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2581064165","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大涨7.15%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581064165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581064165?lang=zh_cn&edition=full","pubTime":"2025-11-05 22:38","pubTimestamp":1762353485,"startTime":"0","endTime":"0","summary":"北京时间2025年11月05日22时38分，Estrella Immunopharma, Inc.股票出现波动，股价快速上涨7.15%。截至发稿，该股报2.45美元/股，成交量3.9399万股，换手率0.11%，振幅5.68%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511052238059755fcda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511052238059755fcda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"1164382933","title":"Estrella Immunopharma 完成剂量组后，DSMB将审查研究数据的安全性和有效性","url":"https://stock-news.laohu8.com/highlight/detail?id=1164382933","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164382933?lang=zh_cn&edition=full","pubTime":"2025-11-03 21:10","pubTimestamp":1762175410,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma 完成剂量组后，DSMB将审查研究数据的安全性和有效性","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"1155605883","title":"Estrella Immunopharma在Starlight-1试验中完成第二剂量组的评估，所有可评估患者均获得完全缓解","url":"https://stock-news.laohu8.com/highlight/detail?id=1155605883","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155605883?lang=zh_cn&edition=full","pubTime":"2025-11-03 21:01","pubTimestamp":1762174878,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma在Starlight-1试验中完成第二剂量组的评估，所有可评估患者均获得完全缓解","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2572604405","title":"Estrella Immunopharma, Inc.盘中异动 急速拉升6.83%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572604405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572604405?lang=zh_cn&edition=full","pubTime":"2025-10-01 21:32","pubTimestamp":1759325538,"startTime":"0","endTime":"0","summary":"北京时间2025年10月01日21时32分，Estrella Immunopharma, Inc.股票出现波动，股价急速拉升6.83%。截至发稿，该股报1.23美元/股，成交量230股，换手率0.00%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001213218a4502d8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001213218a4502d8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2570866901","title":"Estrella Immunopharma, Inc.盘中异动 临近收盘股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570866901","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570866901?lang=zh_cn&edition=full","pubTime":"2025-09-27 03:48","pubTimestamp":1758916115,"startTime":"0","endTime":"0","summary":"北京时间2025年09月27日03时48分，Estrella Immunopharma, Inc.股票出现异动，股价快速拉升5.22%。截至发稿，该股报1.21美元/股，成交量9.4518万股，换手率0.26%，振幅5.22%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927034835a446a484&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927034835a446a484&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2569332067","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大涨7.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569332067","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569332067?lang=zh_cn&edition=full","pubTime":"2025-09-22 21:37","pubTimestamp":1758548220,"startTime":"0","endTime":"0","summary":"北京时间2025年09月22日21时37分，Estrella Immunopharma, Inc.股票出现波动，股价大幅上涨7.21%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Qualigen Therapeutics, Inc.、Mbx Biosciences, Inc.、Metsera, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Onconetix, Inc.、Gri Bio, Inc.较为活跃，换手率分别为2271.51%、122.97%、38.26%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Onconetix, Inc.、Adverum Biotechnologies, Inc.，振幅分别为68.66%、22.86%、19.53%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922213700a72f87b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922213700a72f87b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2568431777","title":"Estrella Immunopharma, Inc.盘中异动 急速上涨5.36%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568431777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568431777?lang=zh_cn&edition=full","pubTime":"2025-09-17 03:30","pubTimestamp":1758051019,"startTime":"0","endTime":"0","summary":"北京时间2025年09月17日03时30分，Estrella Immunopharma, Inc.股票出现波动，股价快速拉升5.36%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509170330209796c1b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509170330209796c1b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2560438124","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨7.16%报0.985美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560438124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560438124?lang=zh_cn&edition=full","pubTime":"2025-08-20 02:41","pubTimestamp":1755628861,"startTime":"0","endTime":"0","summary":"北京时间2025年08月20日02时41分，Estrella Immunopharma, Inc.股票出现波动，股价快速上涨7.16%。截至发稿，该股报0.985美元/股，成交量591股，换手率0.00%，振幅4.02%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.97%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082002410197521bce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082002410197521bce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2558866168","title":"Estrella Immunopharma, Inc.盘中异动 急速上涨5.71%报0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558866168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558866168?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:22","pubTimestamp":1754925766,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时22分，Estrella Immunopharma, Inc.股票出现异动，股价急速上涨5.71%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5561.67%、490.85%、169.04%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811232247a4823ecd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811232247a4823ecd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2557313410","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨5.02%报0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557313410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557313410?lang=zh_cn&edition=full","pubTime":"2025-08-06 00:25","pubTimestamp":1754411132,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日00时25分，Estrella Immunopharma, Inc.股票出现波动，股价急速拉升5.02%。截至发稿，该股报0.870美元/股，成交量2168股，换手率0.01%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为3.18%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080600253294d1a0af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080600253294d1a0af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.estrellabio.com","stockEarnings":[{"period":"1week","weight":-0.1367},{"period":"1month","weight":-0.4231},{"period":"3month","weight":-0.0698},{"period":"6month","weight":0.3638},{"period":"1year","weight":0.0811},{"period":"ytd","weight":-0.2308}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0629},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1774},{"period":"ytd","weight":0.0178}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Estrella Immunopharma, Inc.于2021年1月6日在特拉华州注册成立。该公司是一家临床前阶段的生物制药公司，开发CD19和CD22靶向ARTEMIS T细胞疗法，有能力应对血癌和实体瘤患者的治疗挑战。该公司的使命是利用人类免疫系统的进化力量，改变癌症患者的生活。为了完成这一使命，该公司的主要候选产品EB103利用Eureka的ARTEMIS技术来靶向CD19，一种在几乎所有B细胞白血病和淋巴瘤表面表达的蛋白质。该公司也在开发EB104，它还利用Eureka的ARTEMIS技术，不仅针对CD19，还针对CD22，一种与CD19一样在大多数B细胞恶性肿瘤表面表达的蛋白质。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.061361},{"month":2,"riseRate":0.5,"avgChangeRate":-0.025426},{"month":3,"riseRate":0.5,"avgChangeRate":0.026432},{"month":4,"riseRate":0.75,"avgChangeRate":0.006035},{"month":5,"riseRate":0.25,"avgChangeRate":-0.040145},{"month":6,"riseRate":0.5,"avgChangeRate":0.017516},{"month":7,"riseRate":0.5,"avgChangeRate":0.07367},{"month":8,"riseRate":0.25,"avgChangeRate":-0.054345},{"month":9,"riseRate":0.75,"avgChangeRate":0.07408},{"month":10,"riseRate":0.6,"avgChangeRate":-0.005756},{"month":11,"riseRate":0.8,"avgChangeRate":0.071826},{"month":12,"riseRate":0.2,"avgChangeRate":-0.109506}],"exchange":"NASDAQ","name":"Estrella Immunopharma","nameEN":"Estrella Immunopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Estrella Immunopharma(ESLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Estrella Immunopharma,ESLA,Estrella Immunopharma股票,Estrella Immunopharma股票老虎,Estrella Immunopharma股票老虎国际,Estrella Immunopharma行情,Estrella Immunopharma股票行情,Estrella Immunopharma股价,Estrella Immunopharma股市,Estrella Immunopharma股票价格,Estrella Immunopharma股票交易,Estrella Immunopharma股票购买,Estrella Immunopharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Estrella Immunopharma(ESLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}